Should You Buy Amrize (AMRZ)?

Amrize (NYSE:AMRZ) is one of the Top 13 Stocks That Will Skyrocket.

A stock that’s part of Porter Stansberry and Luke Lango’s “1776 moment” pitch, this firm is what is dubbed “The AI Foundation.” The pitch adds that the firm “is a new spin-off from a multi-billion dollar business that has dominated its industry since 1912.”In fact, the newsletter writer goes one step ahead and markets the firm as being the best investment idea that he has seen in his career. “In my entire career I’ve never – not once – seen a better investment idea,’” he says.

Should You Buy Amrize (AMRZ)?

So what is this investment idea? According to Gumshoe, this firm is Amrize (NYSE:AMRZ) – a Swiss building infrastructure provider. As part of the Trump administration’s efforts to beef up American manufacturing, the firm expanded its Made in America label in April and added it to four more cement plants in the US. Amrize (NYSE: AMRZ) is investing $600 million to expand its US operations, and the Made in America label guarantees end-to-end sourcing from the US.

While we acknowledge the risk and potential of AMRZ as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AMRZ and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1